E-LIB Suche - Ergebnisse für: Marréaud, S.

1

MA17.06 Surgical Results of EORTC 1205, a Randomized Phase ..:

Raskin, J. ; Maat, A.P.W.M. ; Surmont, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S163-S164 , 2023

Link: https://doi.org/10.1016/..

2

OC-0278 Accelerated CH-RT with/without nimorazole for p16- ..:

Grégoire, V. ; Tao, Y. ; Kaanders, J....
Radiotherapy and Oncology. 161 (2021) - p. S187-S188 , 2021

Link: https://doi.org/10.1016/..

3

Surgical safety of immediate versus deferred cytoreductive ..:

Bex, A. ; Mulders, P. ; Jewett, M....
European Urology Supplements. 17 (2018) 2 - p. e1-e2 , 2018

Link: https://doi.org/10.1016/..

4

Prognostic relevance of distant metastases versus locally a..:

Verschoor, A.J. ; Litière, S. ; Marréaud, S....
European Journal of Cancer. 94 (2018) - p. 187-198 , 2018

Link: https://doi.org/10.1016/..

5

European Organisation for Research and Treatment of Cancer ..:

Touati, N. ; Schöffski, P. ; Litière, S....
Clinical Oncology. 30 (2018) 7 - p. 448-454 , 2018

Link: https://doi.org/10.1016/..

6

Cardiac safety, efficacy, and correlation of serial serum H..:

Tryfonidis, Konstantinos ; Marreaud, S. ; Khaled, H....
Breast Cancer Research and Treatment. 163 (2017) 3 - p. 507-515 , 2017

Link: https://doi.org/10.1007/..

7

Impact of chemotherapy in uterine sarcoma (UtS): review of ..:

Ray-Coquard, I. ; Rizzo, E. ; Blay, J.Y....
Gynecologic Oncology. 142 (2016) 1 - p. 95-101 , 2016

Link: https://doi.org/10.1016/..

8

Outcome of uterine sarcoma patients treated with pazopanib:..:

Benson, C. ; Ray-Coquard, I. ; Sleijfer, S....
Gynecologic Oncology. 142 (2016) 1 - p. 89-94 , 2016

Link: https://doi.org/10.1016/..

9

Hypertension (HTN) as a potential biomarker of efficacy in ..:

Duffaud, F. ; Sleijfer, S. ; Litière, S....
European Journal of Cancer. 51 (2015) 17 - p. 2615-2623 , 2015

Link: https://doi.org/10.1016/..

10

3439 Prognostic factors in soft tissue sarcoma patients wit..:

Lindner, L. ; Litiere, S. ; Sleijfer, S....
European Journal of Cancer. 51 (2015) - p. S701 , 2015

Link: https://doi.org/10.1016/..

11

A phase IIb multicentre study comparing the efficacy of tra..:

Bui-Nguyen, B. ; Butrynski, J.E. ; Penel, N....
European Journal of Cancer. 51 (2015) 10 - p. 1312-1320 , 2015

Link: https://doi.org/10.1016/..

12

Brostallicin versus doxorubicin as first-line chemotherapy ..:

Gelderblom, H. ; Blay, J.Y. ; Seddon, B.M....
European Journal of Cancer. 50 (2014) 2 - p. 388-396 , 2014

Link: https://doi.org/10.1016/..

13

An European Organisation for Research and Treatment of Canc..:

Bonnefoi, H. ; Zaman, K. ; Debled, M....
European Journal of Cancer. 49 (2013) 2 - p. 281-289 , 2013

Link: https://doi.org/10.1016/..

14

9400 ORAL Prognostic and Predictive Factors in Advanced Sof..:

Van der Graaf, W.T.A. ; Blay, J.Y. ; Chawla, S....
European Journal of Cancer. 47 (2011) - p. S662 , 2011

Link: https://doi.org/10.1016/..

15

An EORTC phase I study of Bortezomib in combination with ox..:

Caponigro, F. ; Lacombe, D. ; Twelves, C....
European Journal of Cancer. 45 (2009) 1 - p. 48-55 , 2009

Link: https://doi.org/10.1016/..